BRTX — Biorestorative Therapies Balance Sheet
0.000.00%
- $11.63m
- $2.53m
- $0.40m
Annual balance sheet for Biorestorative Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3.06 | 21 | 14.7 | 11.1 | 10.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.017 | 0.005 | 0.016 | 0.019 | 0.188 |
Prepaid Expenses | |||||
Total Current Assets | 3.19 | 21.5 | 15.1 | 11.4 | 11.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.496 | 0.396 | 0.503 | 0.507 | 0.363 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 4.35 | 22.5 | 16.4 | 12.6 | 12.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.04 | 0.364 | 0.44 | 2.61 | 3.75 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.68 | 0.857 | 0.603 | 2.61 | 3.75 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -1.33 | 21.6 | 15.8 | 10 | 8.53 |
Total Liabilities & Shareholders' Equity | 4.35 | 22.5 | 16.4 | 12.6 | 12.3 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |